Columbus McKinnon Corporation
CMCOColumbus McKinnon Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work.
The price is between stages while the P/E sits at the 73rd percentile of its own 1-year range. Underneath, the last four quarters read mixed, and 154% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Columbus McKinnon Corporation trades at $21.6, between stages. That is +31.2% against its own 200-day average. It sits at 88% of a 52-week range of $13 to $23. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is between stages. At $21.6 it trades +31.2% versus its 200-day average and sits at 88% of its 52-week range ($13–$23).
Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved +33% while the S&P 500 moved +24% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Columbus McKinnon Corporation trades at 102.8× P/E, at the pricey end of its own range (73rd percentile). Its long-run median P/E is 79.9×, measured across 1.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 102.8× is at the pricey end of its own range (73rd percentile), against a long-run median of 79.9× measured over 1.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Columbus McKinnon Corporation reads as turning around on its fundamental arc. Turning around — EPS growth swung from −110.1% at the trough to −36.4%, a 2-quarter improving streak, ROCE slipping at -3.9%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +24.0% | +8.2% | — | — |
| Stock price | +53.0% | — | — | — |
4-Factor Sector Score
45.3/100 — rank 10 of 21 in Farm & Heavy Construction Machinery · 52% evidence confidence
Columbus McKinnon Corporation scores 45.3 out of 100 against the 21 companies it is compared with in Farm & Heavy Construction Machinery, ranking 10. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 13.6 + 6 + 8.7 + 17 = 45.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Columbus McKinnon Corporation reported $0.4 B of revenue in the Mar 26 quarter, +76.0% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 6.9% a year. The last full year, FY26, came in at $1.2 B. The last four reported quarters add to $1.2 B.
FY26 revenue came in at $1.2 B (+24.0% on the year), capping 4 years at 6.9% compound. The latest quarter (Mar 26) printed $0.4 B, +76.0% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +24.3% growth against the decade's 6.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +25.0% over the last 4 quarters against +8.5%/yr over the last 8 — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Columbus McKinnon Corporation's operating margin is −34.1% in the Mar 26 quarter, −34.1 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −10.1% to 10.9%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −34.1%, −34.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −10.1%–10.9%.
🚨 Why the margin moved: operating margin went −34.1 pp year on year while gross margin went −9.3 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Columbus McKinnon Corporation posted a net loss of $0.2 B in the Mar 26 quarter. The full FY26 year was a loss of $0.2 B. That loss is 54.5% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 2 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.2 B, null year on year. On the full year, FY26 printed $−0.2 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 154% of Columbus McKinnon Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $−0.1 B of operating cash against $−0.2 B of profit. After $0.0 B of capital spending, $−0.2 B was left as free cash.
FY26: operating cash of $−0.1 B against reported profit of $−0.2 B, leaving free cash of $−0.2 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 154% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Columbus McKinnon Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Columbus McKinnon Corporation earns a ROE of −16% in FY26. Return on invested capital clears the cost of that capital by −1.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −19.3% net margin on 0.25× asset turns.
FY26 ROE is −16%.
🚨 Why the return is what it is — the wiring (FY26): −19.3% net margin × 0.25× asset turns × 3.30× balance-sheet leverage ≈ −15.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 3.5% − 4.9% = a −1.4 pp spread. The 4.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Columbus McKinnon Corporation paid $0.28 per share over the last four reported quarters. The most recent declaration was $0.07 for Mar 26. Against the current price of $21.6 that is a trailing yield of 1.30%, measured on dividends already paid rather than on a forecast.
Columbus McKinnon Corporation paid $0.28 per share across the last four reported quarters, most recently $0.07 for Mar 26. Against the current price of $21.6 the trailing twelve months work out to 1.30% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Columbus McKinnon Corporation carries total debt of $2.4 B against shareholder equity of $1.4 B as of Jun 26, a debt-to-equity of 1.74. On the annual view that ratio went from 0.66 in FY22 to 1.65 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $2.4 B against shareholder equity of $1.4 B — a debt-to-equity of 1.74. On the annual view, debt-to-equity went from 0.66 (FY22) to 1.65 (FY26). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
6.9% of Columbus McKinnon Corporation's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 6.9% of the float is sold short, and at typical trading volumes it would take about 2.9 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Columbus McKinnon Corporation: the Z-score reads 0.65. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.65 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.65.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Blue Bird CorporationBLBD | 64.3/100Mixed-positive evidence81% evidence | LEADER | 20.3/35 Revenue 10.1% · PAT 21.1% · OPM change 1.7 pp 83% evidence | 14.4/25 ROCE 10.4% · OPM 11.1% 76% evidence | 15.2/20 P/E 13.5× · PEG 0.52 65% evidence | 14.4/20 RS sector 17.8% · RS bench 16.8% · 1Y 40.6%11 of 12 weeks ahead 100% evidence |
| Exact sum: 20.3 + 14.4 + 15.2 + 14.4 = 64.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Federal Signal CorporationFSS | 62.4/100Thin evidence · provisional58% evidence | TURNING | 22.3/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 16.2/25 ROCE 6.3% · OPM 15.9% 76% evidence | 9.9/20 P/E 27.7× · PEG — 15% evidence | 14.0/20 RS sector 3.4% · RS bench 2.2% · 1Y 5.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 16.2 + 9.9 + 14 = 62.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Caterpillar Inc.CAT | 60.5/100Mixed-positive evidence81% evidence | FADING | 23.3/35 Revenue 11.8% · PAT -5.8% · OPM change -0.4 pp 83% evidence | 16.1/25 ROCE 5.5% · OPM 17.7% 76% evidence | 8.1/20 P/E 35.3× · PEG 1.72 65% evidence | 13.0/20 RS sector 15.7% · RS bench 15.1% · 1Y 110.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 16.1 + 8.1 + 13 = 60.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4PACCAR IncPCAR | 60.3/100Thin evidence · provisional58% evidence | TURNING | 19.5/35 Revenue — · PAT — · OPM change -1.9 pp 45% evidence | 12.6/25 ROCE 2.7% · OPM 10% 76% evidence | 10.1/20 P/E 25.2× · PEG — 15% evidence | 18.1/20 RS sector 8.9% · RS bench 7.7% · 1Y 39.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 12.6 + 10.1 + 18.1 = 60.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Deere & CompanyDE | 57.2/100Mixed-positive evidence85% evidence | TURNING | 15.9/35 Revenue 4% · PAT -15.7% · OPM change -2 pp 95% evidence | 16.1/25 ROCE 4.3% · OPM 22.5% 76% evidence | 11.8/20 P/E 32.7× · PEG 1.03 65% evidence | 13.4/20 RS sector 4.9% · RS bench 3.7% · 1Y 21%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 16.1 + 11.8 + 13.4 = 57.2 · Decision use: Price leads the evidence: RS versus the benchmark is 3.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6The Manitowoc Company, Inc.MTW | 52.6/100Mixed-positive evidence68% evidence | TURNING | 18.0/35 Revenue 5.2% · PAT -82.6% · OPM change -0.5 pp 62% evidence | 6.0/25 ROCE 0.2% · OPM 0.6% 76% evidence | 14.0/20 P/E 58.3× · PEG 0.14 65% evidence | 14.6/20 RS sector 7.5% · RS bench 6.3% · 1Y 38.3%2 of 12 weeks ahead 70% evidence |
| Exact sum: 18 + 6 + 14 + 14.6 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Oshkosh CorporationOSK | 51.6/100Thin evidence · provisional58% evidence | TURNING | 16.0/35 Revenue — · PAT — · OPM change -4.1 pp 45% evidence | 13.2/25 ROCE 3.4% · OPM 3.5% 76% evidence | 10.6/20 P/E 17.6× · PEG — 15% evidence | 11.8/20 RS sector 1% · RS bench -0.5% · 1Y 16.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 13.2 + 10.6 + 11.8 = 51.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Alamo Group Inc.ALG | 47.4/100Mixed-negative evidence81% evidence | BASING | 16.3/35 Revenue 2.3% · PAT -12.2% · OPM change -1.3 pp 83% evidence | 13.7/25 ROCE 3% · OPM 10.1% 76% evidence | 10.4/20 P/E 19.7× · PEG 1.36 65% evidence | 7.0/20 RS sector -13.2% · RS bench -14.6% · 1Y -23.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.7 + 10.4 + 7 = 47.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Terex CorporationTEX | 46.4/100Thin evidence · provisional58% evidence | ASLEEP | 15.2/35 Revenue — · PAT — · OPM change -10.3 pp 45% evidence | 10.8/25 ROCE 2.8% · OPM -4.7% 76% evidence | 9.3/20 P/E 36.9× · PEG — 15% evidence | 11.1/20 RS sector 3.8% · RS bench 2.6% · 1Y 36%2 of 12 weeks ahead 100% evidence |
| Exact sum: 15.2 + 10.8 + 9.3 + 11.1 = 46.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Columbus McKinnon Corporationthis pageCMCO | 45.3/100Thin evidence · provisional52% evidence | TURNING | 13.6/35 Revenue — · PAT — · OPM change -37 pp 45% evidence | 6.0/25 ROCE -0.6% · OPM -35% 76% evidence | 8.7/20 P/E 82.1× · PEG — 15% evidence | 17.0/20 RS sector 21% · RS bench 19.4% · 1Y 55.3%2 of 12 weeks ahead 70% evidence |
| Exact sum: 13.6 + 6 + 8.7 + 17 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11CNH Industrial N.V.CNH | 44.7/100Mixed-negative evidence81% evidence | BASING | 12.7/35 Revenue -4% · PAT -62.5% · OPM change -3.8 pp 83% evidence | 10.3/25 ROCE 1% · OPM 9.9% 76% evidence | 14.0/20 P/E 35.5× · PEG 0.46 65% evidence | 7.7/20 RS sector -4.9% · RS bench -6.2% · 1Y -9.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 10.3 + 14 + 7.7 = 44.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Wabash National CorporationWNC | 43.4/100Thin evidence · provisional52% evidence | BREAKING OUT | 11.3/35 Revenue — · PAT — · OPM change -99.9 pp 45% evidence | 5.2/25 ROCE -2.7% · OPM -17.3% 76% evidence | 11.3/20 P/E 1.7× · PEG — 15% evidence | 15.6/20 RS sector 15.3% · RS bench 13.4% · 1Y 25.9%9 of 12 weeks ahead 70% evidence |
| Exact sum: 11.3 + 5.2 + 11.3 + 15.6 = 43.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Astec Industries, Inc.ASTE | 43.1/100Mixed-negative evidence75% evidence | ASLEEP | 18.4/35 Revenue 11.5% · PAT 73.3% · OPM change -3.9 pp 83% evidence | 6.7/25 ROCE 1% · OPM 2.3% 76% evidence | 11.7/20 P/E 48.1× · PEG 1.01 65% evidence | 6.3/20 RS sector -6.8% · RS bench -8% · 1Y 21%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.4 + 6.7 + 11.7 + 6.3 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14AGCO CorporationAGCO | 42.7/100Thin evidence · provisional58% evidence | BASING | 20.5/35 Revenue — · PAT — · OPM change 1 pp 45% evidence | 9.8/25 ROCE 1.7% · OPM 3.4% 76% evidence | 11.0/20 P/E 16.6× · PEG — 15% evidence | 1.4/20 RS sector -14.2% · RS bench -15.3% · 1Y -2.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 9.8 + 11 + 1.4 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Aebi Schmidt Holding AGAEBI | 41.1/100Mixed-negative evidence65% evidence | TURNING | 14.6/35 Revenue 61.2% · PAT -60.9% · OPM change -2.4 pp 83% evidence | 9.3/25 ROCE 1.3% · OPM 3.4% 76% evidence | 8.8/20 P/E 80.9× · PEG — 15% evidence | 8.4/20 RS sector -2.3% · RS bench -3.6% · 1Y 20.2%6 of 12 weeks ahead 70% evidence |
| Exact sum: 14.6 + 9.3 + 8.8 + 8.4 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Gencor Industries, Inc.GENC | 38.7/100Mixed-negative evidence75% evidence | BASING | 10.9/35 Revenue -10.3% · PAT -7.1% · OPM change -4.5 pp 83% evidence | 11.0/25 ROCE 2% · OPM 12.5% 76% evidence | 11.4/20 P/E 17× · PEG 1.32 65% evidence | 5.4/20 RS sector -9.1% · RS bench -10.2% · 1Y -2%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.9 + 11 + 11.4 + 5.4 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Titan International, Inc.TWI | 38.1/100Thin evidence · provisional52% evidence | BASING | 16.7/35 Revenue — · PAT — · OPM change -5.1 pp 45% evidence | 7.0/25 ROCE 1.1% · OPM -2.7% 76% evidence | 10.9/20 P/E 16.8× · PEG — 15% evidence | 3.5/20 RS sector -16.4% · RS bench -17.7% · 1Y -8.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.7 + 7 + 10.9 + 3.5 = 38.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Lindsay CorporationLNN | 37.0/100Mixed-negative evidence79% evidence | TURNING | 11.7/35 Revenue -7.1% · PAT -27.3% · OPM change -2.5 pp 95% evidence | 13.1/25 ROCE 2.7% · OPM 11.5% 76% evidence | 7.3/20 P/E 21× · PEG 2.04 65% evidence | 4.9/20 RS sector -12.2% · RS bench -13.5% · 1Y -13.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11.7 + 13.1 + 7.3 + 4.9 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19CEA Industries Inc.BNC | 27.1/100Thin evidence · provisional52% evidence | ASLEEP | 9.6/35 Revenue — · PAT — · OPM change -2254.1 pp 45% evidence | 3.0/25 ROCE -43.5% · OPM -992.9% 76% evidence | 11.5/20 P/E 1.2× · PEG — 15% evidence | 3.0/20 RS sector -63.9% · RS bench -65.1% · 1Y -85.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 9.6 + 3 + 11.5 + 3 = 27.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Hyster-Yale, Inc.HY | 22.6/100Adverse evidence65% evidence | BASING | 4.1/35 Revenue -12.2% · PAT -175.7% · OPM change -5.8 pp 83% evidence | 4.1/25 ROCE -2.8% · OPM -3.5% 76% evidence | 8.5/20 P/E 263.3× · PEG — 15% evidence | 5.9/20 RS sector -8.2% · RS bench -9.3% · 1Y -2.4%2 of 12 weeks ahead 70% evidence |
| Exact sum: 4.1 + 4.1 + 8.5 + 5.9 = 22.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21SunScout Holding LimitedSNSC | 55.7/100Thin evidence · provisional11% evidence | 17.5/35 Revenue — · PAT — · OPM change — 0% evidence | 18.2/25 ROCE 30.5% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 17.5 + 18.2 + 10 + 10 = 55.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Columbus McKinnon Corporation's stock price today?
Columbus McKinnon Corporation trades at $21.6, +53.0% over the past year. The company is valued at $1.0 B. The stock sits at 88% of its 52-week range of $13–$23, +31.2% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 2 weeks. — as of 5 August 2026.
What were Columbus McKinnon Corporation's latest quarterly results?
Columbus McKinnon Corporation reported revenue of $0.4 B and a net loss of $0.2 B for the Mar 26 quarter. Earnings per share were $−5.78. The operating margin was −34.1%, 34.1 pp lower than a year earlier. — as of 5 August 2026.
What is Columbus McKinnon Corporation's revenue?
Columbus McKinnon Corporation reported revenue of $0.4 B in the Mar 26 quarter, +76.0% year on year. For the full FY26 fiscal year, revenue was $1.2 B (+24.0%). Over the last 4 years revenue compounded at 6.9% a year. — as of 5 August 2026.
What is Columbus McKinnon Corporation's profit?
Columbus McKinnon Corporation earned $−0.2 B of net profit in the Mar 26 quarter. Full-year FY26 profit was $−0.2 B. The operating margin ran −34.1% in the latest quarter. — as of 5 August 2026.
What is Columbus McKinnon Corporation's market cap?
Columbus McKinnon Corporation's market capitalisation is $1.0 B at a stock price of $21.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Columbus McKinnon Corporation's P/E ratio?
Columbus McKinnon Corporation trades at a P/E of 102.8×, at the 73rd percentile of its own 1-year range, against a long-run median of 79.9×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Columbus McKinnon Corporation pay a dividend?
Yes — Columbus McKinnon Corporation declared $0.07 per share for Mar 26, and $0.28 per share across the last four reported quarters. — as of 5 August 2026.
What is Columbus McKinnon Corporation's dividend per share?
Columbus McKinnon Corporation's most recently declared dividend is $0.07 per share for Mar 26, giving $0.28 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Columbus McKinnon Corporation's dividend yield?
Columbus McKinnon Corporation's trailing dividend yield is 1.30%: $0.28 declared per share across the last four reported quarters, against a share price of $21.6. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Columbus McKinnon Corporation overvalued?
On its own history, Columbus McKinnon Corporation looks expensive against its own history: its P/E of 102.8× sits at the 73rd percentile of its 1-year range (long-run median 79.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
How is Columbus McKinnon Corporation performing?
Columbus McKinnon Corporation's latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Columbus McKinnon Corporation in?
Turning around — EPS growth swung from −110.1% at the trough to −36.4%, a 2-quarter improving streak, ROCE slipping at -3.9%. The read comes from the last 12 quarters of growth (revenue growth +25.0% latest, profit growth −100.0% latest, eps growth −36.4% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Columbus McKinnon Corporation beating the market?
On recent form, yes — Columbus McKinnon Corporation has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved +33% against the S&P 500's +24% — ahead of the index over the full window. — as of 5 August 2026.
Will Columbus McKinnon Corporation's stock price go up?
This page publishes no price forecast for Columbus McKinnon Corporation. What it measures instead: the stock price is $21.6. Its P/E of 102.8× sits at the 73rd percentile of its own 1-year range. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Columbus McKinnon Corporation?
Somewhat — short interest is 6.9% of Columbus McKinnon Corporation's tradable float, about 2.9 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Columbus McKinnon Corporation have too much debt?
It carries real leverage — Columbus McKinnon Corporation's debt-to-equity is 1.81. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Columbus McKinnon Corporation's capex?
Columbus McKinnon Corporation spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 5 August 2026.
What is Columbus McKinnon Corporation's cash flow?
Columbus McKinnon Corporation generated $−0.1 B of operating cash flow in FY26 and $−0.2 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.2 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Columbus McKinnon Corporation's profit real cash?
Yes — over the last 3 fiscal years, 154% of Columbus McKinnon Corporation's reported profit arrived as operating cash. In FY26, operating cash was $−0.1 B against reported profit of $−0.2 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Columbus McKinnon Corporation?
On the balance sheet, the Z-score reads 0.65 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is Columbus McKinnon Corporation in its business cycle?
Columbus McKinnon Corporation's FY26 operating margin was −10.1%, against a 5-year band of −10.1%–10.9%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −34.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Columbus McKinnon Corporation story?
Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Columbus McKinnon Corporation a stock worth studying right now?
This is not investment advice. The machine read: Columbus McKinnon Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.